Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-17

Clinical Trial Update: ZNN Bactiguard Cephalomedullary Nails PMCF Study

View source ↗

Summary

This is an update on a PMCF study evaluating Zimmer Biomet's ZNN Bactiguard Cephalomedullary Nails for femur fracture repairs; the study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZNN Bactiguard Cephalomedullary Nail

Snippet

Sponsor: Zimmer Biomet | Conditions: Osteotomy, Trochanteric Fractures | Status: ACTIVE_NOT_RECRUITING